Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Thailand New upcoming elections could change cannabis regulations…
  • North Dakota - United States Amended bill would regulate revocation of medical cannabis patients’ ID cards& ...
  • Oklahoma - United States Senate bill to keep grow facilities from places of worship heads to House…
  • Montana - United States Bill to make delta-8 a controlled substance goes to governor…
  • Brazil Superior court to decide on hemp cultivation for medical purposes…
  • Canada Cannabis fees rise in line with inflation…
  • Kentucky - United States Bill to ban delta-8 sales to under-21s land on governor’s desk…
  • Oklahoma - United States House approves extension to Medical Marijuana Authority’s powers…
  • Spain Podemos and allies call for hemp regulation…
  • Belgium Positive notifications list updated…
  • Bulgaria Industrial cannabis THC limit could be increased…
  • Germany Public hearing held over decriminalising cannabis…
View all
News analysis

Wayland agrees to take 51% share in UK medical cannabis company

Written by || 6th December 2018 || News analysis | Companies | Canada Europe United Kingdom

Canadian medical cannabis company Wayland Group has agreed to purchase 51% of the British firm Theros Pharma for £27.8m – if it succeeds in gaining a UK cultivation or import licence ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
Cannabis in the UK now medically legal – up to a point
CBD prescriptions may be just around the corner for UK patients
Canadian firms put faith and cash in Italian CBD producers

CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

© 2023 Tamarind Media Limited (T/A CannIntelligence)
CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.